Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency
- PMID: 23436467
- DOI: 10.1002/ajmg.a.35826
Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency
Abstract
Ganglioside GM3 synthase deficiency is a rare autosomal recessive metabolic disorder characterized by infantile onset of severe irritability and epilepsy, failure to thrive, developmental stagnation, and cortical blindness. Because of the lack of easily recognizable dysmorphism and specific neurologic manifestations, identification of patients with this condition is extremely challenging. Here we report on previously undescribed pigmentary abnormalities in 20 of 38 patients with GM3 synthase deficiency. All 20 of the patients showed freckle-like hyperpigmented macules, ranging in size from 2 to 5 mm in diameter and usually found bilaterally on the extremities, especially the dorsal aspects of the hands and feet. Seven of these patients also had depigmented macules and patches, especially on the face and extremities. These cutaneous changes were asymptomatic, and were not associated with the severity or particular phenotype of the neurologic disease. They became visible only after the first years of life with an increased incidence with advancing age. These distinct pigmentary features are not identified in 54 normal siblings, and may provide a useful clue in identifying patients with ganglioside metabolic disorders.
Copyright © 2013 Wiley Periodicals, Inc.
Similar articles
-
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.Int J Mol Sci. 2022 May 11;23(10):5368. doi: 10.3390/ijms23105368. Int J Mol Sci. 2022. PMID: 35628171 Free PMC article. Review.
-
GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype.Am J Med Genet A. 2016 Aug;170(8):2200-5. doi: 10.1002/ajmg.a.37773. Epub 2016 May 27. Am J Med Genet A. 2016. PMID: 27232954
-
Early growth and development impairments in patients with ganglioside GM3 synthase deficiency.Clin Genet. 2016 May;89(5):625-9. doi: 10.1111/cge.12703. Epub 2016 Jan 20. Clin Genet. 2016. PMID: 26649472
-
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.J Child Neurol. 2018 Nov;33(13):825-831. doi: 10.1177/0883073818791099. Epub 2018 Sep 5. J Child Neurol. 2018. PMID: 30185102 Free PMC article.
-
X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review.Pediatr Dermatol. 2005 Mar-Apr;22(2):122-6. doi: 10.1111/j.1525-1470.2005.22206.x. Pediatr Dermatol. 2005. PMID: 15804299 Review.
Cited by
-
Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function.Glycoconj J. 2014 Dec;31(9):613-22. doi: 10.1007/s10719-014-9563-5. Epub 2014 Oct 29. Glycoconj J. 2014. PMID: 25351657 Free PMC article. Review.
-
Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility.J Invest Dermatol. 2017 Feb;137(2):440-448. doi: 10.1016/j.jid.2016.09.028. Epub 2016 Oct 8. J Invest Dermatol. 2017. PMID: 27729281 Free PMC article.
-
Human genetic disorders of sphingolipid biosynthesis.J Inherit Metab Dis. 2015 Jan;38(1):65-76. doi: 10.1007/s10545-014-9736-1. Epub 2014 Aug 21. J Inherit Metab Dis. 2015. PMID: 25141825 Review.
-
Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights.Int J Mol Sci. 2020 Jul 28;21(15):5349. doi: 10.3390/ijms21155349. Int J Mol Sci. 2020. PMID: 32731387 Free PMC article. Review.
-
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.Int J Mol Sci. 2022 May 11;23(10):5368. doi: 10.3390/ijms23105368. Int J Mol Sci. 2022. PMID: 35628171 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical